Campbell & Co Investment Adviser’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-101,867
Closed -$419K 1124
2026
Q1
$419K Sell
101,867
-238,321
-70% -$1.15M 0.02% 799
2025
Q4
$2.26M Buy
340,188
+320,655
+1,642% +$2.17M 0.11% 292
2025
Q3
$120K Sell
19,533
-27,624
-59% -$215K 0.01% 1037
2025
Q2
$434K Buy
+47,157
New +$483K 0.03% 838
2024
Q3
Sell
-21,118
Closed -$229K 1154
2024
Q2
$229K Buy
+21,118
New +$260K 0.02% 927
2024
Q1
Sell
-130,726
Closed -$1.38M 1173
2023
Q4
$1.38M Buy
130,726
+102,006
+355% +$912K 0.12% 249
2023
Q3
$263K Buy
+28,720
New +$258K 0.03% 763

Other funds holding EOLS

Campbell & Co Investment Adviser's EOLS Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Evolus (EOLS) in Q2 2026, closing a stake of 101,867 shares — an estimated $419K sold.

Campbell & Co Investment Adviser first reported a position in EOLS in Q3 2023 and held it in 7 quarters. The position peaked at $2.26M in Q4 2025. 52 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Evolus position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 101,867 Evolus shares in Q2 2026, an estimated $419K.
  • Campbell & Co Investment Adviser first reported a position in Evolus in Q3 2023 and held it in 7 quarters.
  • Campbell & Co Investment Adviser's Evolus position peaked at $2.26M in Q4 2025.
  • 52 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.